nicardipine has been researched along with Alkalosis, Respiratory in 3 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Alkalosis, Respiratory: A state due to excess loss of carbon dioxide from the body. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to investigate the modification of the resistive inspiratory properties of the respiratory system associated with hypocapnia in the presence of nicardipine." | 7.69 | Combined effects of hypocapnia and nicardipine on airway resistance: a pilot study. ( Combes, P; Fauvage, B, 1997) |
| "The aim of this study was to investigate the modification of the resistive inspiratory properties of the respiratory system associated with hypocapnia in the presence of nicardipine." | 3.69 | Combined effects of hypocapnia and nicardipine on airway resistance: a pilot study. ( Combes, P; Fauvage, B, 1997) |
| "Nicardipine did not cause an increase in ICP." | 2.67 | Combined effects of nicardipine and hypocapnic alkalosis on cerebral vasomotor activity and intracranial pressure in man. ( Combes, P; Durand, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Combes, P | 3 |
| Fauvage, B | 2 |
| Durand, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Dysfunctional Breathing: Multidimensional Characterisation and Assessment Tool[NCT03043469] | 141 participants (Anticipated) | Observational | 2020-08-08 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nicardipine and Alkalosis, Respiratory
| Article | Year |
|---|---|
Combined effects of nicardipine and hypocapnic alkalosis on cerebral vasomotor activity and intracranial pressure in man.
Topics: Adult; Alkalosis, Respiratory; Carotid Arteries; Cerebrovascular Circulation; Humans; Hypocapnia; In | 1991 |
2 other studies available for nicardipine and Alkalosis, Respiratory
| Article | Year |
|---|---|
Combined effects of hypocapnia and nicardipine on airway resistance: a pilot study.
Topics: Airway Resistance; Alkalosis, Respiratory; Analysis of Variance; Calcium Channel Blockers; Female; H | 1997 |
Systemic vasomotor interaction between nicardipine and hypocapnic alkalosis in man.
Topics: Aged; Alkalosis, Respiratory; Blood Gas Analysis; Dose-Response Relationship, Drug; Evaluation Studi | 1992 |